Latest News in the pharma Industry

All

Medicines for Europe calls for pharma supply chain remedies as COVID-19 pandemic worsens

Medicines for Europe calls for pharma supply chain remedies as COVID-19 pandemic worsens

16 Mar 2020

As the global coronavirus pandemic worsens, generics industry association Medicines for Europe has called for all available European pharmaceutical manufacturing to remain open and running at all times and highlighted the risks to the supply chain that...

Read more 
Catalent partners with Biohaven on newly-approved fast-dissolve migraine treatment

Catalent partners with Biohaven on newly-approved fast-dissolve migraine treatment

16 Mar 2020

The US Food and Drug Administration has approved migraine treatment Nurtec ODT, developed by Biohaven and using CDMO Catalent’s proprietary Zydis orally disintegrating tablet technology, the two firms said Monday.

Read more 
FDA grants EUA to Thermo Fisher’s diagnostics test for coronavirus

FDA grants EUA to Thermo Fisher’s diagnostics test for coronavirus

16 Mar 2020

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Thermo Fisher Scientific’s diagnostic test for coronavirus, the contract development and manufacturing organisation said Monday.

Read more 
Technique improves drug delivery system characterization

Technique improves drug delivery system characterization

16 Mar 2020

Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems.

Read more 
Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19

Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19

16 Mar 2020

The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.

Read more 
Contec launches virtual training tool sensitive to social distancing

Contec launches virtual training tool sensitive to social distancing

16 Mar 2020

A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations.

Read more 
Indian pharma supply chain disruption could surpass 2017 if COVID-19 not contained within three months: Ind-Ra

Indian pharma supply chain disruption could surpass 2017 if COVID-19 not contained within three months: Ind-Ra

13 Mar 2020

Indian pharmaceutical supply chain disruption could be far greater than the China environmental regulation-induced shortfall of 2017 If the COVID-19 outbreak is not contained within the next three months, credit ratings agency India Ratings and Researc...

Read more 
New website launching

New website launching

13 Mar 2020

Esteve Química launches its new corporate website with a structure muc more intuitive and funcitional.

Read more 
#FPSneverSTOPS

#FPSneverSTOPS

12 Mar 2020

Following the new provisions of the Italian Government aimed at stop the spread of Coronavirus, we wish to inform you that FPS is currently open and operational, in line with the necessary prevention and security measures.

Read more 
Leadership change at Fujifilm Diosynth Biotechnologies as Meeson appointed CEO

Leadership change at Fujifilm Diosynth Biotechnologies as Meeson appointed CEO

11 Mar 2020

Japanese bio-focused CDMO Fujifilm Diosynth Biotechnologies has announced a change of leadership with president and COO, Martin Meeson taking over as CEO, replacing Steve Bagshaw, who is retiring.

Read more 
FDA postpones overseas inspections through April as COVID-19 cases increase

FDA postpones overseas inspections through April as COVID-19 cases increase

11 Mar 2020

The US Food and Drug Administration has postponed “most foreign inspections” through April in response to the COVID-19 outbreak, the US drug regulator said late Tuesday.

Read more 
Mylan launches first bioequivalent alternative to Advair Diskus in Canada

Mylan launches first bioequivalent alternative to Advair Diskus in Canada

10 Mar 2020

Appropriate asthma and COPD patients provided with a "more affordable alternative to appropriate".

Read more